Investigating how tiny vesicles affect kidney health
Targeting Microvesicles in Kidney Disease
['FUNDING_R21'] · UNIVERSITY OF MISSOURI-COLUMBIA · NIH-10664055
This study is looking at tiny particles called extracellular vesicles that might play a big role in kidney diseases like diabetic nephropathy and polycystic kidney disease, and by using fruit flies to see how these particles work, researchers hope to find new ways to help improve kidney health for people with these conditions.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MISSOURI-COLUMBIA (nih funded) |
| Locations | 1 site (COLUMBIA, UNITED STATES) |
| Trial ID | NIH-10664055 on ClinicalTrials.gov |
What this research studies
This research focuses on understanding the role of extracellular vesicles (EV) in kidney diseases, particularly in diabetic nephropathy and polycystic kidney disease. By studying how these vesicles transport signaling molecules and affect kidney function, the research aims to uncover new therapeutic targets. The approach involves using a model organism, Drosophila melanogaster, to visualize the processes of EV formation and cargo loading in real-time. This could lead to innovative treatments that improve kidney health for patients suffering from chronic kidney conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with diabetic nephropathy or polycystic kidney disease who are seeking new treatment options.
Not a fit: Patients with acute kidney injury or those without chronic kidney disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that improve kidney function and overall health for patients with diabetic kidney disease and other related conditions.
How similar studies have performed: Other research has shown promising results in targeting extracellular vesicles for therapeutic purposes, indicating that this approach has potential for success.
Where this research is happening
COLUMBIA, UNITED STATES
- UNIVERSITY OF MISSOURI-COLUMBIA — COLUMBIA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CHABU, CHISWILI YVES — UNIVERSITY OF MISSOURI-COLUMBIA
- Study coordinator: CHABU, CHISWILI YVES
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.